|
|
Correlation analysis of serum Chemerin,Adropin levels with type 2 diabetes combined with hyperhomocysteinemia |
LIANG Bi-yu1 RUAN Shi-chong2 LIN Zhong-jun3 TAN Guo-ju1 CHEN Shi-yong1 |
1.Department of Endocrinology,People′s Hospital of Yangjiang,Guangdong Province,Yangjiang 529500,China;
2.Department of Respiratory Medicine,People′s Hospital of Yangjiang,Guangdong Province,Yangjiang 529500,China;
3.Department of Nephrology,People′s Hospital of Yangjiang,Guangdong Province,Yangjiang 529500,China |
|
|
Abstract Objective To explore the correlation between serum Chemerin and Adropin levels and type 2 diabetes(T2DM)combined with hyperhomocysteinemia(Hhcy).Methods A total of 168 patients with T2DM admitted to People′s Hospital of Yangjiang from April 2016 to April 2018 were selected as the research objects.According to Hhcy combined or not,they were divided into 81 cases in the simple T2DM group and 87 cases in the T2DM+Hhcy group.50 healthy people who underwent physical examination at the same time were selected as the control group.The basic data and biochemical indicators between the groups were compared,and Pearson correlation analysis was performed.Results The body mass index(BMI),systolic blood pressure(SBP),diastolic blood pressure(DBP),total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),fasting plasma glucose(FPG),HemoglobinA1c(HbA1c),homocysteine(Hcy),Chemerin of T2DM+Hhcy group and T2DM group were higher than those of control group;the HDL-C and Adropin of T2DM+Hhcy group and T2DM group were lower than those of control group,and the differences were statistically significant(P<0.05).The course of disease in T2DM+Hhcy group was longer than that in T2DM group,the BMI,TG,LDL-C,FPG,HbAlc,Hcy,Chemerin in T2DM+Hhcy group were higher than those in T2DM group,and the differences were statistically significant(P<0.05).After Pearson correlation analysis,the course of disease,BMI,LDL-C,FPG,HbA1c,Chemerin were positively correlated with Hcy in T2DM patients,and Adropin was negatively correlated with it(P<0.05).Conclusion Chemerin and Adropin may both participate in the pathological process of Hhcy in T2DM patients.
|
Received: 12 June 2020
|
|
|
|
[14] |
Li L,Xie W,Zheng XL,et al.A novel peptide adropin in cardiovascular diseases[J].Clinica Chimica Acta,2016,453(11):107-113.
|
[15] |
李敏.血清Adropin 蛋白水平在冠心病合并糖尿病患者血清中的观察[J].医药论坛杂志,2015,36(12):84-85.
|
[1] |
高静,段畅,李丽娟.2 型糖尿病发病机制的研究进展[J].医学综述,2015,21(21):3935-3938.
|
[2] |
朱建一,吕志刚,史恒川.同型半胱氨酸对老年2 型糖尿病患者大血管病变的影响[J].实用老年医学,2010,24(2):135-137.
|
[3] |
杨益鹏,刘洋,卢均坤,等.2 型糖尿病患者血浆chemerin水平与其冠脉病变程度的相关性分析[J].现代生物医学进展,2014,14(5):927-929.
|
[4] |
景月月,白宏兴,梁延宏,等.冠心病患者血浆Adropin 蛋白与同型半胱氨酸水平的相关性研究[J].检验医学与临床,2017,14(24):3618-3620.
|
[5] |
中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志,2014,30(10):893-942.
|
[6] |
田思敏,唐明敏,刘洋,等.2 型糖尿病胰岛素抵抗发生机制的研究进展[J].新疆医科大学学报,2015,38(10):1317-1320.
|
[7] |
董燕燕,陈光亮.高同型半胱氨酸血症危害及致病机制研究进展[J].中国药理学通报,2014,30(9):1205-1208.
|
[8] |
彭清,卢建刚,王小洁,等.高血压病患者血清chemerin 与胰岛素抵抗及炎症的关系[J].西部医学,2014,26(1):37-39.
|
[9] |
陈春莲,易玉芳,王志成.2 型糖尿病患者血清chemerin和C 反应蛋白水平及胰岛素抵抗与大血管病变的相关性研究[J].中国全科医学,2013,16(21):2438-2440.
|
[10] |
施良,张浩,李林,等.2 型糖尿病患者血清chemerin 水平与骨密度相关性研究[J].中国骨质疏松杂志,2016,22(1):67-71.
|
[11] |
刘颖,李伶,王毅,等.初诊2 型糖尿病合并高血压患者血浆Chemerin 水平变化及相关因素研究[J].中国糖尿病杂志,2010,18(10):732-734.
|
[12] |
赵鹏,王倩梅,王彦军,等.2 型糖尿病合并冠脉病变患者中急性心肌梗死的发生与血清Adropin 蛋白水平的相关性研究[J].临床急诊杂志,2019,20(04):21-24,30.
|
[13] |
Wong CM,Wang Y,Lee JT,et al.Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice[J].J Boel Chemi,2014,289(37):25 976-25 986.
|
|
|
|